Clinical Trial Detail

NCT ID NCT02228681
Title Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Gynecologic Oncology Group
Indications

endometrial carcinoma

Therapies

Tamoxifen

Medroxyprogesterone

Everolimus + Letrozole

Age Groups: adult

No variant requirements are available.